Protox doses first patient in Phase 2 BPH clinical trial
                   
newswire.ca     May 15, 2008            

VANCOUVER, May 15 /CNW/ - Protox Therapeutics Inc. (TSX:PRX), a leader in the development of receptor targeted fusion proteins, today announced the enrolment and successful dosing of the first patient in a Phase 2 clinical trial evaluating PRX302 to treat benign prostatic hyperplasia (BPH), or... [read full story]                    


View all news articles about*:
Ambulatory America Canada Care Health Hyperplasia Japan MacKenzie Male Medical Michael Moore North Patients Prostatic Research Wood
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

                   

New Prostate Cancer Test is Ready for Commercialization Following Successful Completion of Final...

yahoo.com     10 hrs ago   1 related          

SAVANNAH, Ga.----Health Discovery Corporation today announced that HDC's new gene-based molecular diagnostic test for prostate cancer has now successfully completed it's Phase III double-blind clinical trial and is now ready...                    

comments

7 Alternatives Therapies For An Enlarged Prostate

misterarticle.com     Aug 5, 2008   6 related          

If you are suffering from an enlarged prostate gland then your first port of call must be your doctor so that you can be sure that this is a simple case of benign prostatic hypertrophy and nothing more. Once you have a firm...                    

comments

                   

New Data On Nymox BPH Drug To Be Presented At American Urological Association Meeting In Monterey...

medicalnewstoday.com     Jul 31, 2008   2 related          

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced that new clinical trial data concerning the safety and efficacy of the Company's NX-1207 for benign prostatic hyperplasia (BPH) will be presented at the Annual...                    

comments

Oestrogen And Benign Prostatic Hyperplasia: Effects On Stromal Cell Proliferation And Local...

medicalnewstoday.com     Jul 31, 2008          

UroToday.com - Previous animal studies suggested a role for estrogens in the pathogenesis of benign prostatic hyperplasia (BPH) 1,2. Estrogens interact with two forms of estrogen receptor (ER), ERα and ERβ. We recently...                    

comments